Signaling Pathways
-
A3008 Y-27632 dihydrochloride19 CitationTarget: ROCKSummary: ROCK1 inhibitor
-
A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
-
A3010 MK-2206 dihydrochloride21 CitationTarget: AktSummary: Akt1/2/3 inhibitor
-
A3011 CHIR-99021 (CT99021)2 CitationTarget: GSK-3Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
-
A3012 Ruxolitinib (INCB018424)4 CitationTarget: JAKSummary: JAK inhibitor
-
A3014 BGJ3981 CitationTarget: FGFRSummary: FGFR inhibitor ,potent and selective
-
A3015 BKM1201 CitationTarget: PI3KSummary: Inhibitor of pan-Class I PI3K
-
A3016 PLX-47201 CitationTarget: RafSummary: BRAF kinase inhibitor
-
A3018 Trametinib (GSK1120212)7 CitationTarget: MEKSummary: MEK1 and MEK2 inhibitor, potent and selective
-
A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve